ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 163 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $17,361,000 | -37.0% | 398,194 | -42.9% | 0.61% | -36.1% |
Q1 2018 | $27,539,000 | -46.8% | 697,194 | -54.2% | 0.95% | -53.1% |
Q4 2017 | $51,722,000 | +89.2% | 1,522,566 | +42.0% | 2.04% | +65.3% |
Q3 2017 | $27,344,000 | +289.0% | 1,072,329 | +157.3% | 1.23% | +228.5% |
Q2 2017 | $7,030,000 | – | 416,729 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 505,670 | $34,487,000 | 7.23% |
Asymmetry Capital Management, L.P. | 142,246 | $9,701,000 | 6.67% |
Prosight Management, LP | 137,000 | $9,343,000 | 5.84% |
Avoro Capital Advisors LLC | 4,075,000 | $277,915,000 | 4.84% |
Integral Health Asset Management, LLC | 225,000 | $15,345,000 | 4.22% |
First Light Asset Management, LLC | 617,124 | $42,088,000 | 2.52% |
SECTORAL ASSET MANAGEMENT INC | 322,599 | $22,001,000 | 1.78% |
Avidity Partners Management LP | 943,000 | $64,313,000 | 1.74% |
DAFNA Capital Management LLC | 119,615 | $8,158,000 | 1.71% |
Nicholas Investment Partners, LP | 298,247 | $20,340,000 | 1.28% |